Intellectual Property News - Secerna LLP

Mrna Vaccines (1)

Beyond the Science: Five Intellectual Property Challenges Facing Thermostable Vaccine Developers

News IP Insights 23/08/2026

This article examines five intellectual property challenges that are likely to shape the long-term success of thermostable vaccine developers.

Read more

Secerna Interior Shots September 2024 022 (1)

News, Careers 25/02/2025

Explore a Career in IP: Secerna Taster Day

LEQEMBI

News, A to Z Feature 19/02/2025

A to Z: Drugs in Highlight: L is for LEQEMBI®

Secerna Website Images 2025 (5)

Events, News 17/02/2025

Secerna LLP are presenting at NEPIC Pharma Connect 2025

Secerna Website Images 2025 (6)

Events, News 14/02/2025

Secerna attending Agri-Tech Expo North

KALYDECO

News, A to Z Feature 13/02/2025

A to Z: Drugs in Highlight: K is for KALYDECO®

J Is For JANUVIA® (1)

News, A to Z Feature 06/02/2025

A to Z: Drugs in Highlight: J is for JANUVIA®

EU FLAG Canva

Industry news, News 03/02/2025

UPC finds infringement by way of equivalence for the first time

IMBRUVICA

News, A to Z Feature 30/01/2025

A to Z: Drugs in Highlight: I is for IMBRUVICA®

Secerna Website Images 2025 (4)

Industry news, News 27/01/2025

Unlocking Faster Cancer Treatments: The Power of Project Orbis

14 15 16 17 18 19 20 21 22 23 24